GBI Share Price

Open 0.14 Change Price %
High 0.14 1 Day -0.02 -12.50
Low 0.14 1 Week -0.02 -12.50
Close 0.14 1 Month -0.01 -6.67
Volume 5000 1 Year -0.06 -30.00
52 Week High 0.31
52 Week Low 0.12
GBI Important Levels
Resistance 2 0.14
Resistance 1 0.14
Pivot 0.14
Support 1 0.14
Support 2 0.14
ASX Australia Most Active Stocks
TLS 3.87 -10.62%
TLS 3.87 -10.62%
TLS 3.87 -10.62%
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
LYC 0.14 0.00%
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
AZS 0.02 100.00%
AZS 0.02 100.00%
AZZ 0.50 78.57%
AZZ 0.50 78.57%
BNV 0.03 50.00%
PMQ 0.03 50.00%
QRX 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
AIR 0.02 -33.33%
AIR 0.02 -33.33%
AIR 0.02 -33.33%
AIR 0.02 -33.33%
More..

Genera Biosystems Ltd (ASX: GBI)

GBI Technical Analysis 4
As on 17th Aug 2017 GBI Share Price closed @ 0.14 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.21 & Sell for SHORT-TERM with Stoploss of 0.16 we also expect STOCK to react on Following IMPORTANT LEVELS.
GBI Target for August
1st Target up-side 0.18
2nd Target up-side 0.2
3rd Target up-side 0.21
1st Target down-side 0.14
2nd Target down-side 0.12
3rd Target down-side 0.11
GBI Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.generabiosystems.com
GBI Address
GBI
Small Technologies Cluster
1 Dalmore Drive
Scoresby, VIC 3179
Australia
Phone: 61 3 9763 1287
Fax: 61 3 9763 2817
GBI Latest News
Genera Biosystems Ltd (GBI.AX) Seeing Increased Volatility in Session   Union Trade Journal   - 17th Aug 17
Schaff Cycle Trend on Watch For Genera Biosystems Ltd (GBI.AX)   Melville Review   - 16th Aug 17
APN Outdoor Group Limited (ASX:APO): What does the future look like?   Simply Wall St   - 27th Jun 17
Is Cabcharge Australia Limited (ASX:CAB) Financially Strong Enough To Weather ...   Simply Wall St   - 10th Mar 17
Genera Biosystems distributing molecular diagnostics assays in India   Proactive Investors Australia   - 17th Jul 15
The HPV Testing Market Growing at 16% CAGR to 2019   PR Newswire (press release)   - 22nd Jun 15
IVD (In Vitro Diagnostic) Testing World Markets 2015   PR Newswire (press release)   - 27th Jan 15
Next Generation Cancer Diagnostics: Technologies and Global Markets   PR Newswire (press release)   - 04th Sep 14
Genera Biosystems eyes growing market for HPV test   Proactive Investors Australia   - 29th Apr 14
Searching for Australia's Best Biotech Stocks   TheBull.com.au   - 26th Mar 12
Interactive Technical Analysis Chart Genera Biosystems Ltd ( GBI ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Genera Biosystems Ltd
GBI Business Profile
Genera Biosystems Limited develops and commercialises multiplexed molecular diagnostic tests in Australia. The company develops molecular diagnostic tests based upon its proprietary AmpaSand bead-based technology that facilitates the multiplexing of tests by identifying individual clusters of beads within a larger pool. Its products include RTIplex, a multiplexed and automated PCR based test for upper respiratory tract analytes; and PapType, an in vitro molecular diagnostic test for the simultaneous detection and genotyping of high risk and low risk types of human papillomaviruses. Genera Biosystems Limited is based in Scoresby, Australia.